Clinical Trials Logo

Clinical Trial Summary

The main autoimmune bullous dermatoses are pemphigus and cicatricial pemphigoid. Pemphigus is an autoimmune dermatological disease characterized by the production of anti-desmoclesin antibodies 1 and 3, affecting the skin and mucous membranes.The cicatricial pemphigoid is an autoimmune dermatological disease, characterized by the production of anti-zone antibodies of the basal membrane and characterized by a predominant mucosal involvement. Mycophenolic acid (MPA) is an increasingly used form of corticosteroid. Despite its increasing use, pharmacokinetics in autoimmune bullous dermatosis remain little studied.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02993133
Study type Interventional
Source University Hospital, Limoges
Contact
Status Completed
Phase Phase 3
Start date December 2016
Completion date April 2019